Clinical Characteristics of Ischemic Colitis According to Location

por Chang, Ho Jin, Chung, Chul Woon, Ko, Kwang Hyun, Kim, Jong Woo
Publicado 2011

An Evaluation of the Effectiveness of Hyaluronidase in the Selective Nerve Root Block of Radiculopathy: A Double Blind, Controlled Clinical Trial

por Ko, Sang-Bong, Vaccaro, Alexander R, Chang, Ho-Jin, Shin, Dong-Young
Publicado 2015

Anti-Cancer SERCA Inhibitors Targeting Sorafenib-Resistant Human Papillary Thyroid Carcinoma

por Chang, Hang-Seok, Kim, Yonjung, Lee, So Young, Yun, Hyeok Jun, Chang, Ho-Jin, Park, Ki Cheong
Publicado 2023

Long-term survival of patients with anaplastic thyroid cancer after multimodal treatment

por Lee, Haejun, Kim, Soo Young, Kim, Seok-Mo, Chang, Ho-Jin, Lee, Yong Sang, Park, Cheong Soo, Chang, Hang-Seok
Publicado 2020

Solitary lateral neck node metastasis in papillary thyroid carcinoma

por Kim, Seok-Mo, Chun, Ki Won, Chang, Ho Jin, Kim, Bup-Woo, Lee, Yong Sang, Chang, Hang-Seok, Park, Cheong Soo
Publicado 2014

Effects of Anti-Cancer Drug Sensitivity-Related Genetic Differences on Therapeutic Approaches in Refractory Papillary Thyroid Cancer

por Yun, Hyeok Jun, Kim, Minki, Kim, Sang Yong, Fang, Sungsoon, Kim, Yonjung, Chang, Hang-Seok, Chang, Ho-Jin, Park, Ki Cheong
Publicado 2022

Synergistic Anticancer Activity of N-Hydroxy-7-(2-Naphthylthio) Heptanomide, Sorafenib, and Radiation Therapy in Patient-Derived Anaplastic Thyroid Cancer Models

por Yun, Hyeok Jun, Kim, Hee Jun, Kim, Jungmin, Kim, Sang Yong, Chang, Hang-Seok, Park, Cheong Soo, Chang, Ho-Jin, Park, Ki Cheong
Publicado 2021

Anti-cancer Effects of HNHA and Lenvatinib by the Suppression of EMT-Mediated Drug Resistance in Cancer Stem Cells()()

por Lee, Yong Sang, Kim, Seok-Mo, Kim, Bup-Woo, Chang, Ho Jin, Kim, Soo Young, Park, Cheong Soo, Park, Ki Cheong, Chang, Hang-Seok
Publicado 2018

SoLAT (Sorafenib Lenvatinib alternating treatment): a new treatment protocol with alternating Sorafenib and Lenvatinib for refractory thyroid Cancer

por Kim, Soo Young, Kim, Seok-Mo, Chang, Ho-Jin, Kim, Bup-Woo, Lee, Yong Sang, Park, Cheong Soo, Park, Ki Cheong, Chang, Hang-Seok
Publicado 2018

Potential anti-cancer effect of N-hydroxy-7-(2-naphthylthio) heptanomide (HNHA), a novel histone deacetylase inhibitor, for the treatment of thyroid cancer

por Kim, Seok-Mo, Park, Ki-Cheong, Jeon, Jeong-Yong, Kim, Bup-Woo, Kim, Hyeung-Kyoo, Chang, Ho-Jin, Choi, Seung-Hoon, Park, Cheong-Soo, Chang, Hang-Seok
Publicado 2015

Synergistic Activity of N-hydroxy-7-(2-naphthylthio) Heptanomide and Sorafenib Against Cancer Stem Cells, Anaplastic Thyroid Cancer

por Park, Ki Cheong, Kim, Seok-Mo, Jeon, Jeong Yong, Kim, Bup-Woo, Kim, Hyeung Kyoo, Chang, Ho Jin, Lee, Yong Sang, Kim, Soo Young, Choi, Seung Hoon, Park, Cheong Soo, Chang, Hang-Seok
Publicado 2017

Corrigendum to “Synergistic Activity of N-Hydroxy-7-(2-Naphthylthio) Heptanomide and Sorafenib against Cancer Stem Cells, Anaplastic Thyroid Cancer” [Neoplasia 19 (2017) 145-153]...

por Park, Ki Cheong, Kim, Seok-Mo, Jeon, Jeong Yong, Kim, Bup-Woo, Kim, Hyeung Kyoo, Chang, HoJin, Lee, Yong Sang, Kim, Soo Young, Choi, Seung Hoon, Park, Cheong Soo, Chang, Hang-Seok
Publicado 2017